Beyond the Heart: Why Metabolic Gains Are the True Drivers of GLP-1RA Cardioprotection

Highlights

Genetic evidence suggests that higher GLP-1 receptor (GLP-1R) expression is causally linked to a reduced risk of both type 2 diabetes mellitus (T2DM) and myocardial infarction (MI).

The cardioprotective effects against MI are largely driven by metabolic improvements, specifically glycated hemoglobin (HbA1c), body mass index (BMI), triglyceride levels, and blood pressure.

Specialty calculators

Browse calculators

For clinical reference; use professional judgment.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply